[Results of a prospective observational study of the effectiveness of the complex drug Homeovox in adult patients with various types of dysphonia].

Autor:	Osipenko EV; National Medical Research Center for Otorhinolaryngology, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia., Karneeva OV; National Medical Research Center for Otorhinolaryngology, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia., Kim IA; National Medical Research Center for Otorhinolaryngology, Moscow, Russia.; Pirogov Russian National Research Medical University, Moscow, Russia., Orlova OS; National Medical Research Center for Otorhinolaryngology, Moscow, Russia.; Moscow Pedagogical State University, Moscow, Russia.; FFederal Center for Brain and Neurotechnology, Moscow, Russia., Kotelnikova NM; National Medical Research Center for Otorhinolaryngology, Moscow, Russia., Mikhalevskaya IA; National Medical Research Center for Otorhinolaryngology, Moscow, Russia., Krivykh YS; National Medical Research Center for Otorhinolaryngology, Moscow, Russia., Isaeva ML; National Medical Research Center for Otorhinolaryngology, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Vestnik otorinolaringologii [Vestn Otorinolaringol] 2022; Vol. 87 (4), pp. 71-78.
DOI:	10.17116/otorino20228704171
Abstrakt:	The voice as the most important means of communication is of great importance in a person's life. Every year the number of specialties for which voice and speech are a key tool of professional activity increases. Diseases of the vocal apparatus reduce the ability to work, and for some people pose a threat of professional unfitness. The relevance of the study is determined not only by the significant prevalence of dysphonia, but also by the insufficient effectiveness of existing methods of treating voice disorders. Objective: To evaluate the clinical efficacy and safety of the use of the drug Homeovox in patients with acute and chronic catarrhal laryngitis as monotherapy. To fulfill the set goal of the study, the following tasks were solved: evaluation of the clinical effectiveness of the drug Homeovox as monotherapy for various types of dysphonia; evaluation of the effectiveness of the drug Homeovox as monotherapy from the 1st day of use. Material and Methods: The basis for the implementation of the tasks was the analysis of the results of the examination and treatment of 60 patients with voice disorders aged 18 to 75 years. Among them, 10 (17%) patients with acute laryngitis and 50 (83%) patients with chronic laryngitis. To establish the diagnosis, a comprehensive examination was carried out, involving examination, videolaryngostroboscopy, acoustic analysis of the voice. The study design included three patient visits, during which the functional state of the vocal apparatus was examined by subjective and objective methods. Results: As a result of the treatment with the use of the drug Homeovox, the efficacy and safety of this drug in the treatment of dysphonia in adult patients with acute and chronic laryngitis from the first days of therapy has been proven, which is confirmed by the method of videolaryngostroboscopy and acoustic analysis of the voice. Conclusion: The drug Homeovox is an effective, safe remedy and can be included in the complex treatment of laryngeal pathology in order to increase its effectiveness and achieve a therapeutic effect in a shorter time, manifested by an improvement in the clinical and functional state of larynx.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu